
High-mobility group box 1 is a promising diagnostic and therapeutic monitoring biomarker in Cancers: A review
Author(s) -
Seidu A. Richard
Publication year - 2018
Publication title -
aims molecular science
Language(s) - English
Resource type - Journals
eISSN - 2372-028X
pISSN - 2372-0301
DOI - 10.3934/molsci.2018.4.183
Subject(s) - medicine , biomarker , prostate cancer , melanoma , oncology , cancer , hmgb1 , angiogenesis , pathology , cancer research , inflammation , biology , biochemistry